The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-Point Inhibitors Resemble Those Seen in Ipex Patients

AuthID
P-01A-87F
3
Author(s)
Tipo de Documento
Letter
Year published
2025
Publicado
in JOURNAL OF CLINICAL IMMUNOLOGY, ISSN: 0271-9142
Volume: 45, Número: 1
Indexing
Publication Identifiers
Pubmed: 41032161
SCOPUS: 2-s2.0-105017776650
Wos: WOS:001586560700001
Source Identifiers
ISSN: 0271-9142
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.